Phase 1 Study to Assess the Safety and Tolerability of TAT4 Gel in Healthy Volunteers

NCT02647853 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

16

Enrollment

INDUSTRY

Sponsor class

Conditions

Nasolabial Folds
Lipoatrophy
Lipodystrophy

Interventions

DRUG: TAT4 Gel concentration A
DRUG: TAT4 Gel concentration B
DRUG: Placebo

Sponsor

Topokine Therapeutics, Inc.